ASRT
Price
$11.60
Change
-$0.25 (-2.11%)
Updated
Feb 5, 02:11 PM (EDT)
Capitalization
76.1M
34 days until earnings call
Intraday BUY SELL Signals
IRWD
Price
$4.57
Change
+$0.08 (+1.78%)
Updated
Feb 5, 03:10 PM (EDT)
Capitalization
728.8M
7 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASRT vs IRWD

Header iconASRT vs IRWD Comparison
Open Charts ASRT vs IRWDBanner chart's image
Assertio Holdings
Price$11.60
Change-$0.25 (-2.11%)
Volume$144
Capitalization76.1M
Ironwood Pharmaceuticals
Price$4.57
Change+$0.08 (+1.78%)
Volume$150
Capitalization728.8M
ASRT vs IRWD Comparison Chart in %
ASRT
Daily Signal:
Gain/Loss:
IRWD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ASRT vs. IRWD commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASRT is a Buy and IRWD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (ASRT: $11.85 vs. IRWD: $4.49)
Brand notoriety: ASRT and IRWD are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ASRT: 48% vs. IRWD: 55%
Market capitalization -- ASRT: $76.1M vs. IRWD: $728.8M
ASRT [@Pharmaceuticals: Generic] is valued at $76.1M. IRWD’s [@Pharmaceuticals: Generic] market capitalization is $728.8M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASRT’s FA Score shows that 0 FA rating(s) are green whileIRWD’s FA Score has 0 green FA rating(s).

  • ASRT’s FA Score: 0 green, 5 red.
  • IRWD’s FA Score: 0 green, 5 red.
According to our system of comparison, IRWD is a better buy in the long-term than ASRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASRT’s TA Score shows that 6 TA indicator(s) are bullish while IRWD’s TA Score has 2 bullish TA indicator(s).

  • ASRT’s TA Score: 6 bullish, 5 bearish.
  • IRWD’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ASRT is a better buy in the short-term than IRWD.

Price Growth

ASRT (@Pharmaceuticals: Generic) experienced а +0.34% price change this week, while IRWD (@Pharmaceuticals: Generic) price change was -6.37% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.85%. For the same industry, the average monthly price growth was -2.19%, and the average quarterly price growth was +12.81%.

Reported Earning Dates

ASRT is expected to report earnings on Mar 11, 2026.

IRWD is expected to report earnings on Feb 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.85% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRWD($729M) has a higher market cap than ASRT($76.1M). IRWD YTD gains are higher at: 33.086 vs. ASRT (30.651). IRWD has higher annual earnings (EBITDA): 129M vs. ASRT (4.53M). IRWD has more cash in the bank: 140M vs. ASRT (60M). ASRT has less debt than IRWD: ASRT (39.9M) vs IRWD (598M). IRWD has higher revenues than ASRT: IRWD (339M) vs ASRT (137M).
ASRTIRWDASRT / IRWD
Capitalization76.1M729M10%
EBITDA4.53M129M4%
Gain YTD30.65133.08693%
P/E RatioN/A24.89-
Revenue137M339M40%
Total Cash60M140M43%
Total Debt39.9M598M7%
FUNDAMENTALS RATINGS
ASRT vs IRWD: Fundamental Ratings
ASRT
IRWD
OUTLOOK RATING
1..100
675
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
4434
P/E GROWTH RATING
1..100
9999
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRWD's Valuation (64) in the Pharmaceuticals Other industry is in the same range as ASRT (74) in the Pharmaceuticals Major industry. This means that IRWD’s stock grew similarly to ASRT’s over the last 12 months.

IRWD's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ASRT (100) in the Pharmaceuticals Major industry. This means that IRWD’s stock grew similarly to ASRT’s over the last 12 months.

ASRT's SMR Rating (96) in the Pharmaceuticals Major industry is in the same range as IRWD (100) in the Pharmaceuticals Other industry. This means that ASRT’s stock grew similarly to IRWD’s over the last 12 months.

IRWD's Price Growth Rating (34) in the Pharmaceuticals Other industry is in the same range as ASRT (44) in the Pharmaceuticals Major industry. This means that IRWD’s stock grew similarly to ASRT’s over the last 12 months.

IRWD's P/E Growth Rating (99) in the Pharmaceuticals Other industry is in the same range as ASRT (99) in the Pharmaceuticals Major industry. This means that IRWD’s stock grew similarly to ASRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASRTIRWD
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ASRT
Daily Signal:
Gain/Loss:
IRWD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOUHY16.350.52
+3.25%
South32 Ltd.
EACO87.00N/A
N/A
EACO Corp.
APGP0.07N/A
N/A
AmpliPay Group Inc.
LBTSF15.47N/A
N/A
Almirall SA
WTHVF0.16N/A
-2.87%
Westhaven Gold Corp.

ASRT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASRT has been closely correlated with TEVA. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if ASRT jumps, then TEVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASRT
1D Price
Change %
ASRT100%
-1.17%
TEVA - ASRT
77%
Closely correlated
-3.56%
DVAX - ASRT
74%
Closely correlated
+0.19%
TAK - ASRT
72%
Closely correlated
+1.78%
COLL - ASRT
70%
Closely correlated
+1.41%
IRWD - ASRT
66%
Closely correlated
-6.37%
More

IRWD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRWD has been loosely correlated with TEVA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IRWD jumps, then TEVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
-6.37%
TEVA - IRWD
58%
Loosely correlated
-3.56%
VTRS - IRWD
53%
Loosely correlated
+4.97%
INDV - IRWD
44%
Loosely correlated
-3.13%
BIOA - IRWD
40%
Loosely correlated
+1.21%
ALKS - IRWD
31%
Poorly correlated
-0.99%
More